serw-MX  [xml]  

 DeCS Categories

C19 Endocrine System Diseases .
C19.787 Polyendocrinopathies, Autoimmune .
C20 Immune System Diseases .
C20.111 Autoimmune Diseases .
C20.111.750 Polyendocrinopathies, Autoimmune .
D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.150 Benzylidene Compounds .
D02.455.426.559.389.150.700 Stilbenes .
D02.455.426.559.389.150.700.175 Diethylstilbestrol .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.656 Peptide Hydrolases .
D08.811.277.656.300 Endopeptidases .
D08.811.277.656.300.760 Serine Endopeptidases .
D08.811.277.656.300.760.635 Plasminogen Activators .
D08.811.277.656.300.760.635.075 Anistreplase .
D08.811.277.656.300.775 Streptokinase .
D08.811.277.656.300.775.075 Anistreplase .
D08.811.277.656.959 Serine Proteases .
D08.811.277.656.959.350 Serine Endopeptidases .
D08.811.277.656.959.350.635 Plasminogen Activators .
D08.811.277.656.959.350.635.075 Anistreplase .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.124 Blood Proteins .
D12.776.124.125 Blood Coagulation Factors .
D12.776.124.125.662 Plasminogen Activators .
D12.776.124.125.662.537 Streptokinase .
D12.776.124.125.662.537.075 Anistreplase .
 Synonyms & Historicals
Diethylstilbestrol .
Agostilben .
Apstil .
Diethylstilbestrol, (Z)-Isomer .
Diethylstilbestrol, Disodium Salt .
Distilbène .
Stilbene Estrogen .
Tampovagan .
Estrogen, Stilbene .
Stilbestrol .
A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) .
Anistreplase .
BRL-26921 .
Eminase .
Iminase .
BRL 26921 .
BRL26921 .
Anisoylated Plasminogen-Streptokinase Activator Complex .
An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents. .
Polyendocrinopathies, Autoimmune .
AIRE Deficiency .
APS Type 1 .
Autoimmune Polyendocrine Syndrome, Type 2 .
Autoimmune Polyendocrine Syndrome, Type II .
Autoimmune Polyendocrinopathy Syndrome Type 1 .
Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy .
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy .
Autoimmune Polyglandular Syndrome Type I .
Autoimmune Polyglandular Syndrome Type II .
Autoimmune Polyglandular Syndrome Type III .
Autoimmune Polyglandular Syndrome, Type 1 .
Autoimmune Polyglandular Syndrome, Type 3 .
Autoimmune Polyglandular Syndrome, Type I .
Autoimmune Syndrome Type III, Polyglandular .
Diabetes Mellitus, Addison Disease, Myxedema .
Diabetes Mellitus, Addison's Disease, Myxedema .
Multiple Endocrine Deficiency Syndrome, Type 2 .
Polyendocrine Autoimmune Syndrome, Type II .
Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy, Autoimmune .
Polyglandular Autoimmune Syndrome, Type 1 .
Polyglandular Autoimmune Syndrome, Type 2 .
Polyglandular Autoimmune Syndrome, Type 3 .
Polyglandular Autoimmune Syndrome, Type I .
Polyglandular Deficiency Syndrome, Type 2 .
Polyglandular Type III Autoimmune Syndrome .
Schmidt Syndrome .
AIRE Deficiencies .
Autoimmune Polyendocrinopathy .
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy .
Deficiency, AIRE .
Polyendocrinopathy Candidiasis Ectodermal Dystrophy, Autoimmune .
Polyendocrinopathy, Autoimmune .
Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, Autoimmune .
Syndrome, Schmidt .
Syndrome, Schmidt's .
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy .
Autoimmune Syndrome Type I, Polyglandular .
Autoimmune Syndrome Type II, Polyglandular .
Polyglandular Type I Autoimmune Syndrome .
Polyglandular Type II Autoimmune Syndrome .
Schmidt's Syndrome .
Autoimmune diseases affecting multiple endocrine organs. Type I is characterized by childhood onset and chronic mucocutaneous candidiasis (CANDIDIASIS, CHRONIC MUCOCUTANEOUS), while type II exhibits any combination of adrenal insufficiency (ADDISON'S DISEASE), lymphocytic thyroiditis (THYROIDITIS, AUTOIMMUNE;), HYPOPARATHYROIDISM; and gonadal failure. In both types organ-specific ANTIBODIES against a variety of ENDOCRINE GLANDS have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present. .